Stockscreener 앱 받기
1.48
8.03%
0.11
Actuate Therapeutics Inc 주식(ACTU)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
Actuate (ACTU) Results Check: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Closing Reaction: The Stock Gains 16.04% for the Current SessionInvestor Earnings Call - vinanet.vn
Actuate (ACTU) Results Review: The EPS Result Is Below Expectation in the Available Record; Share Move: Shares Move 0.95% Up at the CloseRevenue Estimate Trend - vinanet.vn
Actuate Therapeutics (ACTU) Holds $1.00 After 1.31% Gain, Pinned Between Key Support and ResistanceBullish Percent Index - vinanet.vn
Actuate Therapeutics stock gets FDA clearance for elraglusib trial By Investing.com - Investing.com Canada
Actuate Therapeutics (ACTU) Gains 3.58% to $1.01, Approaches Key Resistance at $1.06Bullish Pattern Stocks - Vinanet
Actuate Therapeutics Inc (ACTU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Actuate Therapeutics (ACTU) Pushes 3.58% Higher, Tests $1.06 Resistance ZoneButterfly Setup - dars.gov.et
Actuate Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Actuate Therapeutics (ACTU) CEO RSUs Vest, 120,521 Shares Withheld for Taxes - Stock Titan
Actuate Therapeutics (NASDAQ: ACTU) narrows loss but warns on cash runway - Stock Titan
Actuate Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Actuate Therapeutics (ACTU) Holds Near $0.97 as Support Test LoomsButterfly Setup - vinanet.vn
ACTU Q1 2026 Earnings: Wider-than-Expected Loss Reflects Ongoing R&D InvestmentEarnings Outlook Update - Vinanet
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
ETFs Investing in Actuate Therapeutics, Inc. Stocks - TradingView
Actuate Therapeutics Inc (ACTU) Stock News Today - TradingKey
Actuate Therapeutics (ACTU) Surges 8.85% to $1.23 as Buyers Defend Key SupportOvernight Profile - vinanet.vn
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
Actuate Therapeutics, Inc. Revenue Breakdown – NASDAQ:ACTU - TradingView
Rodman & Renshaw Initiates Actuate Therapeutics(ACTU.US) With Buy Rating, Announces Target Price $6 - Moomoo
Actuate Therapeutics stock initiated with buy rating at Rodman & Renshaw - Investing.com
Actuate Therapeutics Inc (ACTU) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Actuate Therapeutics Inc (ACTU) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Actuate Therapeutics Inc (ACTU) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Actuate Therapeutics Inc (ACTU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Actuate Therapeutics Inc (ACTU) Valuation: PE, PB & Fair Value Analysis - TradingKey
ACTU|Actuate Therapeutics Inc|Price:1.170|Chg%:-0.010 - TradingKey
Actuate Therapeutics Inc (ACTU) Cash Flow - TradingKey
ACTU|Actuate Therapeutics Inc|Price:1.230|Chg%:+0.170 - TradingKey
Actuate Therapeutics Inc (ACTU) Balance Sheet - TradingKey
Actuate Therapeutics Inc (ACTU) Income Statement - TradingKey
Actuate Therapeutics Inc (ACTU) Institutional Confidence - TradingKey
Actuate Therapeutics Inc (ACTU) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ACTU|Actuate Therapeutics Inc|Price:1.140|Chg%:-0.040 - TradingKey
ACTU|Actuate Therapeutics Inc|Price:1.185|Chg%:-0.075 - TradingKey
Actuate Therapeutics Inc (ACTU) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Actuate Therapeutics (ACTU) Faces Selling Pressure as Stock Slides to $1.26MFI Oversold - dars.gov.et
Actuate Therapeutics Inc. (ACTU) Q1 2026 Earnings: EPS Miss of 8.6% Reflects Continued Pre-Revenue Investment PhaseEPS Guidance Update - dars.gov.et
Actuate Therapeutics, Inc. Files Form 8-K: NASDAQ Compliance Update and Company Details (July 2026) - Minichart
Actuate Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
ACTU Q1 2026 Earnings: EPS Misses Estimates as Stock Declines 13%EPS Consistency Score - vinanet.vn
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Actuate Therapeutics (ACTU) Surges 17.8% as Momentum Builds After Support TestLow Risk Entry Stocks - vinanet.vn
ACTU Q1 2026 Earnings: EPS Misses Estimates as Pipeline Progress Drives Stock RallyDividend Growth Analysis - dars.gov.et
Actuate Therapeutics, Inc.(NasdaqGM: ACTU) dropped from Russell 2000 Dynamic Index - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM: ACTU) dropped from Russell 3000E Index - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM: ACTU) dropped from Russell 2500 Index - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM: ACTU) dropped from Russell 3000 Index - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM: ACTU) dropped from Russell 2000 Index - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Unicycive Therapeutics (UNCY) - The Globe and Mail
Price to book forward of Actuate Therapeutics, Inc. – NASDAQ:ACTU - TradingView
Price to sales forward of Actuate Therapeutics, Inc. – NASDAQ:ACTU - TradingView
Number of shareholders of Actuate Therapeutics, Inc. – NASDAQ:ACTU - TradingView
Price to earnings forward of Actuate Therapeutics, Inc. – NASDAQ:ACTU - TradingView
Actuate Therapeutics (ACTU) Declines Sharply – Key Support Tested at $1.73Double Top - dars.gov.et
Actuate Therapeutics, Inc. Actuals & Estimates (NASDAQ:ACTU) - TradingView
ACTU Forecast — Price Target — Prediction for 2027 - TradingView
Actuate Therapeutics (ACTU) Finds Its Footing Near Key Support After a Modest GainLast Point Resistance - dars.gov.et
Actuate Therapeutics (ACTU) Holds Near Key Support After Modest GainIV Crush Alert - dars.gov.et
0.86%
0.31%
자본화:
|
볼륨(24시간):